packageTunlametinib

tunlametinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tunlametinib is an investigational MEK inhibitor being studied as an anticancer agent. It is not yet approved for general use; it remains in clinical investigation.

Summary written by glm-5.3-flash from Wikidata Q130282613 and the WHO ATC classification; not checked by a person.

name:tunlametinib
ATC codes:L01EE06
DrugBank:DB18791
PubChem CID:71621329
Wikidata:Q130282613
formula:C16H12F2IN3O3S
molar mass:491.246 g/mol (PubChem CID 71621329)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown